Weeks after being arrested on charges of security fraud, Martin Shkreli, a Wall Street tycoon who gained notoriety for buying the rights of drugs and then dramatically raising their prices, received a subpoena to appear before a Congressional committee investigating price gouging in the pharmaceutical industry.
The House Committee on Oversight and Government Reform delivered a subpoena to Shkreli's attorneys, demanding his presence at a hearing on Tuesday, the New York Times reports.
The brash executive responded to the subpoena with characteristic nonchalance on Twitter:
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
